Suvai Gunasekaran

Counselor


  737 N Michigan Ave Ste 1600, Chicago
     Illinois, 60611-6652
  608-692-5127    Maps & Directions
Suvai Gunasekaran is a Chicago, Illinois based counselor who is specialized as Counselor. Her current practice location is 737 N Michigan Ave Ste 1600, Chicago. Patients can book an appointment with her at 608-692-5127.
Suvai Gunasekaran is a trained and licensed mental health professional who helps individuals, couples, or groups manage and overcome emotional, psychological, behavioral, or relationship challenges. She works with people dealing with anxiety, depression, mood disorders, trauma, post-traumatic stress disorder (PTSD), grief and loss etc. She support her clients by understanding their thoughts, emotions, and behaviors.
Complete Profile:
Suvai Gunasekaran speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Suvai Gunasekaran
Specialization: Counselor
Gender:Female
Accepts Medicare Assignment:No
Practice Address:737 N Michigan Ave Ste 1600, Chicago,
Illinois, 60611-6652
Phone:608-692-5127
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number: 1609335264
NPI Enumeration Date: 13 Mar, 2019
NPI Last Update On: 13 Mar, 2019

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 850 N Dewitt Pl Apt 15k,
Chicago, Illinois
Zip: 60611-7322
Phone Number: 608-692-5127
Patients can reach Suvai Gunasekaran at 737 N Michigan Ave Ste 1600, Chicago, Illinois or can call to book an appointment on 608-692-5127.
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 June, 2025.

Comments/ Reviews: